» Articles » PMID: 33178967

Radiomics for Radiation Oncologists: Are We Ready to Go?

Overview
Journal BJR Open
Specialty Radiology
Date 2020 Nov 12
PMID 33178967
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Radiomics have emerged as an exciting field of research over the past few years, with very wide potential applications in personalised and precision medicine of the future. Radiomics-based approaches are still however limited in daily clinical practice in oncology. This review focus on how radiomics could be incorporated into the radiation therapy pipeline, and globally help the radiation oncologist, from the tumour diagnosis to follow-up after treatment. Radiomics could impact on all steps of the treatment pipeline, once the limitations in terms of robustness and reproducibility are overcome. Major ongoing efforts should be made to collect and share data in the most standardised manner possible.

Citing Articles

Systematic review and meta-analysis on the classification metrics of machine learning algorithm based radiomics in hepatocellular carcinoma diagnosis.

Mohd Haniff N, Ng K, Kamal I, Mohd Zain N, Abdul Karim M Heliyon. 2024; 10(16):e36313.

PMID: 39253167 PMC: 11382069. DOI: 10.1016/j.heliyon.2024.e36313.


Automation and artificial intelligence in radiation therapy treatment planning.

Jones S, Thompson K, Porter B, Shepherd M, Sapkaroski D, Grimshaw A J Med Radiat Sci. 2023; 71(2):290-298.

PMID: 37794690 PMC: 11177028. DOI: 10.1002/jmrs.729.


Morphometry-based radiomics for predicting therapeutic response in patients with gliomas following radiotherapy.

Sherminie L, Jayatilake M, Hewavithana B, Weerakoon B, Vijithananda S Front Oncol. 2023; 13:1139902.

PMID: 37664038 PMC: 10470056. DOI: 10.3389/fonc.2023.1139902.


Beyond diagnosis: is there a role for radiomics in prostate cancer management?.

Stanzione A, Ponsiglione A, Alessandrino F, Brembilla G, Imbriaco M Eur Radiol Exp. 2023; 7(1):13.

PMID: 36907973 PMC: 10008761. DOI: 10.1186/s41747-023-00321-4.


Predicting Local Failure after Partial Prostate Re-Irradiation Using a Dosiomic-Based Machine Learning Model.

Pirrone G, Matrone F, Chiovati P, Manente S, Drigo A, DOnofrio A J Pers Med. 2022; 12(9).

PMID: 36143276 PMC: 9505150. DOI: 10.3390/jpm12091491.


References
1.
van Griethuysen J, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V . Computational Radiomics System to Decode the Radiographic Phenotype. Cancer Res. 2017; 77(21):e104-e107. PMC: 5672828. DOI: 10.1158/0008-5472.CAN-17-0339. View

2.
Teshima K, Murakami R, Tomitaka E, Nomura T, Toya R, Hiraki A . Radiation-induced parotid gland changes in oral cancer patients: correlation between parotid volume and saliva production. Jpn J Clin Oncol. 2009; 40(1):42-6. DOI: 10.1093/jjco/hyp113. View

3.
Sala E, Mema E, Himoto Y, Veeraraghavan H, Brenton J, Snyder A . Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging. Clin Radiol. 2016; 72(1):3-10. PMC: 5503113. DOI: 10.1016/j.crad.2016.09.013. View

4.
Houweling A, Philippens M, Dijkema T, Roesink J, Terhaard C, Schilstra C . A comparison of dose-response models for the parotid gland in a large group of head-and-neck cancer patients. Int J Radiat Oncol Biol Phys. 2009; 76(4):1259-65. DOI: 10.1016/j.ijrobp.2009.07.1685. View

5.
Yin Q, Hung S, Wang L, Lin W, Fielding J, Rathmell W . Associations between Tumor Vascularity, Vascular Endothelial Growth Factor Expression and PET/MRI Radiomic Signatures in Primary Clear-Cell-Renal-Cell-Carcinoma: Proof-of-Concept Study. Sci Rep. 2017; 7:43356. PMC: 5335708. DOI: 10.1038/srep43356. View